Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
5996.25
Change Change %
-56.55 -0.93%

Updated:18 Oct, 2019, 15:59 PM IST

BSE
6100.40
Change Change %
45.10 0.74%

Updated:18 Oct, 2019, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Elara Capital
N/A
27-02-2019 Buy 5972.10 6600.00
N/A
Closed Short (1M)
27-03-2019

Elara Capital Recommends 'Accumulate' On Sanofi India

According to Elara Capital, Sanofi India's portfolio is skewed more towards a high-growing chronic portfolio. The company's top products, such as Lantus, Insuman and Allerga, along with line extensions of Amaryl remain resilient, the brokerage adds.

Top